These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 19732168)
1. Impact of family structure on stimulant use among children with attention-deficit/hyperactivity disorder. Rabbani A; Alexander GC Health Serv Res; 2009 Dec; 44(6):2060-78. PubMed ID: 19732168 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013 [TBL] [Abstract][Full Text] [Related]
4. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013. Albert M; Rui P; Ashman JJ NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186 [TBL] [Abstract][Full Text] [Related]
5. Determinants of inter-practice variation in ADHD diagnosis and stimulant prescribing: cross-sectional database study of a national surveillance network. Hoang U; James AC; Liyanage H; Jones S; Joy M; Blair M; Rigby M; Lusignan S BMJ Evid Based Med; 2019 Aug; 24(4):155-161. PubMed ID: 30765384 [TBL] [Abstract][Full Text] [Related]
6. Cardiac screening prior to stimulant treatment of ADHD: a survey of US-based pediatricians. Leslie LK; Rodday AM; Saunders TS; Cohen JT; Wong JB; Parsons SK Pediatrics; 2012 Feb; 129(2):222-30. PubMed ID: 22250023 [TBL] [Abstract][Full Text] [Related]
7. Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales. Salmelainen P N S W Public Health Bull; 2002 Jan; 13 Suppl 1():1-65. PubMed ID: 12189396 [No Abstract] [Full Text] [Related]
8. Recent trends in stimulant medication use among U.S. children. Zuvekas SH; Vitiello B; Norquist GS Am J Psychiatry; 2006 Apr; 163(4):579-85. PubMed ID: 16585430 [TBL] [Abstract][Full Text] [Related]
9. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Visser SN; Lesesne CA; Perou R Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592 [TBL] [Abstract][Full Text] [Related]
10. Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands. Faber A; Kalverdijk LJ; de Jong-van den Berg LT; Hugtenburg JG; Minderaa RB; Tobi H Eur Child Adolesc Psychiatry; 2010 Feb; 19(2):159-66. PubMed ID: 19894075 [TBL] [Abstract][Full Text] [Related]
11. Knowledge, Attitudes, and Practice Patterns of Health Professionals Toward Medical and Non-medical Stimulant Use by Young Adults. Loskutova NY; Waterman J; Callen E; Staton EW; Bullard E; Shields J J Am Board Fam Med; 2020; 33(1):59-70. PubMed ID: 31907247 [TBL] [Abstract][Full Text] [Related]
12. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD. Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459 [TBL] [Abstract][Full Text] [Related]
13. Medication management of stimulants in pediatric practice settings: a national perspective. Hoagwood K; Jensen PS; Feil M; Vitiello B; Bhatara VS J Dev Behav Pediatr; 2000 Oct; 21(5):322-31. PubMed ID: 11064959 [TBL] [Abstract][Full Text] [Related]
14. Physician practices to prevent ADHD stimulant diversion and misuse. Colaneri N; Keim S; Adesman A J Subst Abuse Treat; 2017 Mar; 74():26-34. PubMed ID: 28132697 [TBL] [Abstract][Full Text] [Related]
15. Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood. Brinker A; Mosholder A; Schech SD; Burgess M; Avigan M J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):328-33. PubMed ID: 17630866 [TBL] [Abstract][Full Text] [Related]
16. Variations in Physician Attitudes Regarding ADHD and Their Association With Prescribing Practices. Sheldrick RC; Leslie LK; Rodday AM; Parsons SK; Saunders TS; Wong JB J Atten Disord; 2015 Jul; 19(7):569-77. PubMed ID: 23142852 [TBL] [Abstract][Full Text] [Related]
18. Stimulant prescribing for attention deficit hyperactivity disorder (ADHD): what guides clinicians in their choice of an upper limit for dose titration? Poulton AS; Paterson R Australas Psychiatry; 2020 Oct; 28(5):568-572. PubMed ID: 32093503 [TBL] [Abstract][Full Text] [Related]
19. Factors Associated with Attention Deficit Hyperactivity Disorder Medication Use in Community Care Settings. Kamimura-Nishimura KI; Epstein JN; Froehlich TE; Peugh J; Brinkman WB; Baum R; Gardner W; Langberg JM; Lichtenstein P; Chen D; Kelleher KJ J Pediatr; 2019 Oct; 213():155-162.e1. PubMed ID: 31300310 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. Goldman LS; Genel M; Bezman RJ; Slanetz PJ JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]